Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Add Agronomics Limited (ANIC) by Ben McPoland in The Motley Fool
- Buy Halfords Group (HFD) by Chris Bailey in ShareProphets
- Buy Warehouse Reit (WHR) by Zaven Boyrazian in The Motley Fool
- Buy JD Sports Fashion (JD.) by Christopher Ruane in The Motley Fool
- Buy British American Tobacco (BATS) by Christopher Ruane in The Motley Fool
- Buy Tesco (TSCO) by Christopher Ruane in The Motley Fool
- Outperform Ceres Power Holdings (CWR) by Credit Suisse
- Buy BAE Systems (BA.) by Citi
- Buy Horizonte Minerals (HZM) by Bank of America
- Buy Jet2 (JET2) by UBS
- Buy Aviva (AV.) by UBS
- Buy Ferguson (FERG) by UBS
- Sell Persimmon (PSN) by UBS
- Sell Abrdn (ABDN) by Redburn
- Sell Abrdn (ABDN) by Deutsche Bank
- Buy WH Smith (SMWH) by Berenberg
- Buy Trainline (TRN) by Berenberg
- Underperform Pets at Home Group (PETS) by RBC Capital
- Outperform Halfords Group (HFD) by RBC Capital
- Outperform Rotork (ROR) by RBC Capital
Vectura Group (VEC)
Health Care Sector
Members only
To view this content and much more please Sign Up
NOTE: This is based on 127 open tips for this company
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |